JungSun Lee

Affiliations: 
2014-2017 Psychiatry Neuroimaging Laboratory, Department of Psychiatry Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States 
Google:
"JungSun Lee"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Jo YT, Joo SW, Choi W, et al. (2024) White matter tract alterations in schizophrenia identified by DTI-based probabilistic tractography: a multisite harmonisation study. Acta Neuropsychiatrica. 1-10
Joo SW, Jo YT, Ahn S, et al. (2023) Structural impairment in superficial and deep white matter in schizophrenia. Acta Neuropsychiatrica. 1-21
Joo SW, Jo YT, Kim Y, et al. (2023) Structural variability of the cerebral cortex in schizophrenia and its association with clinical symptoms. Psychological Medicine. 1-10
Jo YT, Lee JS, Park J, et al. (2023) Linguistic anomalies observed in the Sentence Completion Test in patients with schizophrenia. Cognitive Neuropsychiatry. 1-11
Cetin-Karayumak S, Lyall AE, Di Biase MA, et al. (2023) Characterization of the extracellular free water signal in schizophrenia using multi-site diffusion MRI harmonization. Molecular Psychiatry
Jo YT, Park SY, Park J, et al. (2022) Linguistic anomalies in the language of patients with schizophrenia. Schizophrenia Research. Cognition. 31: 100273
Seitz-Holland J, Wojcik JD, Cetin-Karayumak S, et al. (2022) Cognitive deficits, clinical variables, and white matter microstructure in schizophrenia: a multisite harmonization study. Molecular Psychiatry
Joo SW, Kim H, Jo YT, et al. (2022) One-Year Clinical Outcomes Following Electroconvulsive Therapy for Patients with Schizophrenia: A Nationwide Health Insurance Data-Based Study. Neuropsychiatric Disease and Treatment. 18: 1645-1652
Joo SW, Kim H, Jo YT, et al. (2022) Risk of treatment discontinuation and psychiatric hospitalization associated with early dose reduction of antipsychotic treatment in first-episode schizophrenia: A Nationwide, Health Insurance Data-based Study: Antipsychotic treatment in schizophrenia: Antipsychotic treatment in schizophrenia. Psychiatry and Clinical Neurosciences
Jo YT, Joo SW, Ahn S, et al. (2021) Use of olanzapine compared with clozapine for treatment-resistant schizophrenia in a real-world setting: nationwide register-based study. Bjpsych Open. 7: e142
See more...